LOGIN  |  REGISTER

Recent Insider Transactions - Quince Therapeutics (NASDAQ: QNCX)

Follow NASDAQ:QNCX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ QNCX Quince Therapeutics
Hannah Brendan / officer: CBO, COO & CCO
06/18/2025
Buy
$1.20
37,736
$45K
334,276
NASDAQ QNCX Quince Therapeutics
Hannah Brendan / officer: CBO, COO & CCO
06/18/2025
Buy
$1.20
37,736
$45K
37,736
NASDAQ QNCX Quince Therapeutics
Ryan Charles S. / officer: President
06/18/2025
Buy
$1.20
7,548
$9K
130,009
NASDAQ QNCX Quince Therapeutics
Ryan Charles S. / officer: President
06/18/2025
Buy
$1.20
7,548
$9K
7,548
NASDAQ QNCX Quince Therapeutics
Thye Dirk / director, officer: CEO and CMO
06/18/2025
Buy
$1.20
150,944
$181K
994,885
NASDAQ QNCX Quince Therapeutics
Thye Dirk / director, officer: CEO and CMO
06/18/2025
Buy
$1.20
150,944
$181K
150,944
NASDAQ QNCX Quince Therapeutics
RYAN UNA S / director
06/04/2025
Buy
$1.09
27,000
$29K
27,000
NASDAQ QNCX Quince Therapeutics
Benatti Luca / director
06/04/2025
Buy
$1.09
27,000
$29K
27,000
NASDAQ QNCX Quince Therapeutics
Senner Christopher J. / director
06/04/2025
Buy
$1.09
27,000
$29K
27,000
NASDAQ QNCX Quince Therapeutics
Lamond David / director
06/04/2025
Buy
$1.09
27,000
$29K
27,000
NASDAQ QNCX Quince Therapeutics
McLoughlin Margaret / director
06/04/2025
Buy
$1.09
27,000
$29K
27,000
NASDAQ QNCX Quince Therapeutics
Patni Rajiv / director
06/04/2025
Buy
$1.09
27,000
$29K
27,000
NASDAQ QNCX Quince Therapeutics
Bray June / director
06/04/2025
Buy
$1.09
27,000
$29K
27,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous